{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:16:55Z","timestamp":1792279015381,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardio-Oncology"],"DOI":"10.1186\/s40959-026-00494-y","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:46:00Z","timestamp":1776822360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sacubitril\/valsartan for the prevention of cancer therapy\u2013related cardiac dysfunction: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Yee-Jen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsin","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Wei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Sheng","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"4","key":"494_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","volume":"31","author":"J Herrmann","year":"2022","unstructured":"Herrmann J, Lenihan D, Armenian S, et al. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J Jan. 2022;31(4):280\u201399. https:\/\/doi.org\/10.1093\/eurheartj\/ehab674.","journal-title":"Eur Heart J Jan"},{"issue":"41","key":"494_CR2","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"1","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, Lopez-Fernandez T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Nov. 2022;1(41):4229\u2013361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244.","journal-title":"Eur Heart J Nov"},{"key":"494_CR3","doi-asserted-by":"publisher","unstructured":"Fornaro A, Olivotto I, Rigacci L, et al. Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience. Eur J Heart Fail. May 2018;20(5):898\u2013906. https:\/\/doi.org\/10.1002\/ejhf.1049.","DOI":"10.1002\/ejhf.1049"},{"issue":"10","key":"494_CR4","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1161\/CIRCRESAHA.121.318223","volume":"14","author":"VS Hahn","year":"2021","unstructured":"Hahn VS, Zhang KW, Sun L, Narayan V, Lenihan DJ, Ky B. Heart Failure With Targeted Cancer Therapies: Mechanisms and Cardioprotection. Circ Res May. 2021;14(10):1576\u201393. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318223.","journal-title":"Circ Res May"},{"issue":"1","key":"494_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaccao.2022.01.101","volume":"4","author":"T Omland","year":"2022","unstructured":"Omland T, Heck SL, Gulati G. The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol Mar. 2022;4(1):19\u201337. https:\/\/doi.org\/10.1016\/j.jaccao.2022.01.101.","journal-title":"JACC CardioOncol Mar"},{"issue":"3","key":"494_CR6","doi-asserted-by":"publisher","first-page":"101628","DOI":"10.1016\/j.jacadv.2025.101628","volume":"4","author":"K Katogiannis","year":"2025","unstructured":"Katogiannis K, Ikonomidis I, Farmakis D, et al. Effect of Sacubitril\/Valsartan or Enalapril on Left Ventricular Function in Patients With Hematologic Malignancies Treated With Bone Marrow Transplantation: A Randomized Controlled Trial. JACC Adv Mar. 2025;4(3):101628. https:\/\/doi.org\/10.1016\/j.jacadv.2025.101628.","journal-title":"JACC Adv Mar"},{"issue":"11","key":"494_CR7","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1002\/ejhf.3758","volume":"27","author":"YL Hsu","year":"2025","unstructured":"Hsu YL, Lee CH, Chung WP, et al. Primary cardioprotective effect of sacubitril\/valsartan in breast cancer patients receiving adjuvant therapy. Eur J Heart Fail Nov. 2025;27(11):2141\u201351. https:\/\/doi.org\/10.1002\/ejhf.3758.","journal-title":"Eur J Heart Fail Nov"},{"issue":"16","key":"494_CR8","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1161\/CIRCULATIONAHA.125.076616","volume":"21","author":"T Omland","year":"2025","unstructured":"Omland T, Heck SL, Holte E, et al. Sacubitril\/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial. Circulation Oct. 2025;21(16):1136\u201345. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.076616.","journal-title":"Circulation Oct"},{"issue":"25","key":"494_CR9","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.125.073322","volume":"23","author":"MG Bonatto","year":"2025","unstructured":"Bonatto MG, Avila MS, Ayub Ferreira SM, et al. Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial. Circulation Dec. 2025;23(25):1742\u201355. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.073322.","journal-title":"Circulation Dec"},{"issue":"10","key":"494_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.echo.2015.06.011","volume":"28","author":"KE Farsalinos","year":"2015","unstructured":"Farsalinos KE, Daraban AM, Unlu S, Thomas JD, Badano LP, Voigt JU. Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors: The EACVI\/ASE Inter-Vendor Comparison Study. J Am Soc Echocardiogr Oct. 2015;28(10):1171\u201381. e2.","journal-title":"J Am Soc Echocardiogr Oct"},{"issue":"6","key":"494_CR11","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.echo.2015.01.021","volume":"28","author":"Y Nagata","year":"2015","unstructured":"Nagata Y, Takeuchi M, Mizukoshi K, et al. Intervendor variability of two-dimensional strain using vendor-specific and vendor-independent software. J Am Soc Echocardiogr Jun. 2015;28(6):630\u201341. https:\/\/doi.org\/10.1016\/j.echo.2015.01.021.","journal-title":"J Am Soc Echocardiogr Jun"},{"issue":"22","key":"494_CR12","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation Jun 2. 2015;131(22):1981\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013777.","journal-title":"Circulation Jun 2"},{"issue":"3","key":"494_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/eurheartj\/ehae496","volume":"16","author":"B Rivero-Santana","year":"2025","unstructured":"Rivero-Santana B, Saldana-Garcia J, Caro-Codon J, et al. Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score. Eur Heart J Jan. 2025;16(3):273\u201384. https:\/\/doi.org\/10.1093\/eurheartj\/ehae496.","journal-title":"Eur Heart J Jan"},{"issue":"1","key":"494_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jaccao.2019.08.006","volume":"1","author":"M Vaduganathan","year":"2019","unstructured":"Vaduganathan M, Hirji SA, Qamar A, et al. Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients with Cancer Undergoing Chemotherapy. JACC CardioOncol Sep. 2019;1(1):54\u201365. https:\/\/doi.org\/10.1016\/j.jaccao.2019.08.006.","journal-title":"JACC CardioOncol Sep"},{"issue":"27","key":"494_CR15","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/eurheartj\/ehab843","volume":"14","author":"C Lewinter","year":"2022","unstructured":"Lewinter C, Nielsen TH, Edfors LR, et al. A systematic review and meta-analysis of beta-blockers and renin-angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. Eur Heart J Jul. 2022;14(27):2562\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehab843.","journal-title":"Eur Heart J Jul"},{"issue":"2","key":"494_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40119-025-00401-z","volume":"14","author":"W Harmouch","year":"2025","unstructured":"Harmouch W, Thakker R, Dang A, et al. ACEi and ARBs as Primary Prevention of Cancer Therapy-Related Cardiomyopathy in Patients Undergoing Chemotherapy with Anthracyclines: A Systematic Review and Meta-Analysis. Cardiol Ther Jun. 2025;14(2):141\u201359. https:\/\/doi.org\/10.1007\/s40119-025-00401-z.","journal-title":"Cardiol Ther Jun"},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"131219","DOI":"10.1016\/j.ijcard.2023.131219","volume":"15","author":"D D\u2019Amario","year":"2023","unstructured":"D\u2019Amario D, Laborante R, Bianchini E, et al. Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials. Int J Cardiol Nov. 2023;15:391:131219. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131219.","journal-title":"Int J Cardiol Nov"},{"issue":"25 Pt A","key":"494_CR18","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"1","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. Jul 2014;1(25 Pt A):2751\u201368. https:\/\/doi.org\/10.1016\/j.jacc.2014.01.073.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"494_CR19","doi-asserted-by":"publisher","first-page":"e70126","DOI":"10.1111\/eci.70126","volume":"56","author":"V Aponte Ribero","year":"2026","unstructured":"Aponte Ribero V, Baretella O, Del Giovane C, et al. Target trial emulation of statin discontinuation in multimorbid older adults with polypharmacy. Eur J Clin Invest Jan. 2026;56(1):e70126. https:\/\/doi.org\/10.1111\/eci.70126.","journal-title":"Eur J Clin Invest Jan"},{"issue":"1","key":"494_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40360-019-0298-6","volume":"25","author":"Y Ma","year":"2019","unstructured":"Ma Y, Bai F, Qin F, et al. Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials. BMC Pharmacol Toxicol Apr. 2019;25(1):18. https:\/\/doi.org\/10.1186\/s40360-019-0298-6.","journal-title":"BMC Pharmacol Toxicol Apr"},{"issue":"2","key":"494_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ejhf.1631","volume":"22","author":"L Michel","year":"2020","unstructured":"Michel L, Mincu RI, Mahabadi AA, et al. Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis. Eur J Heart Fail Feb. 2020;22(2):350\u201361. https:\/\/doi.org\/10.1002\/ejhf.1631.","journal-title":"Eur J Heart Fail Feb"},{"issue":"2","key":"494_CR22","doi-asserted-by":"publisher","first-page":"e014419","DOI":"10.1161\/CIRCIMAGING.122.014419","volume":"16","author":"N Marzlin","year":"2023","unstructured":"Marzlin N, Hays AG, Peters M, et al. Myocardial Work in Echocardiography. Circ Cardiovasc Imaging Feb. 2023;16(2):e014419. https:\/\/doi.org\/10.1161\/CIRCIMAGING.122.014419.","journal-title":"Circ Cardiovasc Imaging Feb"}],"container-title":["Cardio-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40959-026-00494-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00494-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40959-026-00494-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:40:06Z","timestamp":1780454406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40959-026-00494-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1186\/s40959-026-00494-y","relation":{},"ISSN":["2057-3804"],"issn-type":[{"value":"2057-3804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a systematic review and meta-analysis of previously published studies and did not involve direct interaction with human participants or access to identifiable individual-level data. Accordingly, institutional review board approval and informed consent were not required and were waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}